
Argentina- Fundación GEP opposed Gilead´s patent application on remdesivir
Fundación GEP has filed this week a patent opposition against Gilead patent application on remdesivir before Argentinean Patent Office. GEP has requested…
RedLAM
News and releases in English: 15 articles. Most of our news is published in Spanish.

Fundación GEP has filed this week a patent opposition against Gilead patent application on remdesivir before Argentinean Patent Office. GEP has requested…

Between October 12th and 19th, RedLAM is in Geneva participating of the “Week of Peoples”, a wake up call to social movements worldwide to contribute to the…
Río de Janeiro, September 10th, 2015 – On August 31st (Rio de Janeiro) and December 2nd (Sao Paulo) a special edition of the AIDS Film Festival took place…
FGEP´s Executive Director, Mrs Lorena Di Giano, participated at the Debate Panel on Medicines’ Public Policies, along with representatives of the Ministry…
Brasilia, October 21st, 2015 – Last October 20th there was a public hearing on the current patent law reform in Brazil . The hearing took place in the…

Last August 31st, officials from Argentina's Ministry of Health met to discuss and build a new state policy on HIV/AIDS and declared that the national…

Since November 2014, IFARMA and other organizations have asked the Colombian government to declare access to cancer drug ‘imatinib’ of public interest under…

Buenos aires, September 2015 - UNAIDS´s Executive Director, Michel Sidibé, visit Argentina and Chile in his first time visit to Latin American region as…

July 29 th 2015 – Yesterday the World Day to Combat Viral Hepatitis was commemorated worldwide. The GTPI (Intellectual Property Working Group) chose this…

BUENOS AIRES - On World Viral Hepatitis Day, Fundación Grupo Efecto Positivo (FGEP) held a meeting with officials from Argentina’s Ministry of Health,…

July 23 rd 2015 Fundación GEP CONTACT: Nicolás Miranda – comunicacionfgep@gmail.com BUENOS AIRES – On Tuesday July 21st members of Fundación GEP met with…

In spite of a 35% price reduction, a compulsory license must be applied for Atazanavir in Perú The Peruvian Ministry of Health informed that it has reached…